Health Technology Assessment (Apr 2004)
Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation
Abstract
No abstracts available.
Health Technology Assessment (Apr 2004)